Activated Sodium Chlorite Formulation for Ocular Antimicrobial Efficacy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing antiseptic agents like povidone-iodine cause ocular discomfort and vision loss, necessitating a more effective and less irritating antimicrobial solution for ocular and skin disinfection.
Innovation Solution
Sodium chlorite compositions activated in buffers with pH between 2 and 7.6, combined with non-ionic surfactants, provide rapid-onset antimicrobial activity with reduced ocular irritation, achieving up to 50,000 times greater efficacy than povidone-iodine.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If povidone-iodine is used for skin disinfection, then antimicrobial efficacy is improved, but ocular irritation and toxicity worsen
Solution Approach 1:
The patent changes the chemical composition parameters by using sodium chlorite instead of povidone-iodine, and adjusts the pH parameter to range from 2 to 7.6 to optimize antimicrobial activity while reducing ocular irritation. This parameter change resolves the contradiction by maintaining efficacy while reducing harm.
Solution Approach 2:
The patent introduces non-ionic surfactants as intermediary substances that enhance the antimicrobial action of sodium chlorite while simultaneously reducing ocular irritation. The surfactant acts as a mediator that improves the therapeutic index by modifying how the active ingredient interacts with ocular tissues.
2Reliability
If sodium chlorite concentration is increased to enhance antimicrobial activity, then antimicrobial efficacy is improved, but potential toxicity may worsen
Solution Approach 1:
The patent optimizes the sodium chlorite concentration parameter within a specific range (800-8000 ppm) and combines it with pH adjustment to achieve high antimicrobial activity at lower concentrations, thereby reducing potential toxicity while maintaining efficacy.
Solution Approach 2:
The patent creates a composite formulation combining sodium chlorite with non-ionic surfactants and buffers, where the composite works synergistically to enhance antimicrobial activity while the surfactant and buffer components reduce the toxic effects of sodium chlorite on ocular tissues.
3Reliability
If pH is lowered to activate sodium chlorite, then antimicrobial efficacy is improved, but ocular comfort may worsen
Solution Approach 1:
The patent carefully controls the pH parameter within a broad range (2-7.6) and uses non-ionic surfactants to buffer the effects of lower pH, allowing activation of sodium chlorite while maintaining ocular comfort through the soothing properties of the surfactant.
Solution Approach 2:
The non-ionic surfactant serves as an intermediary that protects ocular tissues from the harsh effects of low pH while allowing sodium chlorite to remain activated. The surfactant forms a protective interface between the activated antimicrobial agent and the sensitive ocular surface.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The sodium chlorite compositions demonstrate enhanced antimicrobial efficacy with minimal ocular toxicity, suitable for ocular and skin disinfection, including surgical site preparation, without the adverse effects associated with povidone-iodine.
Implementation Method 1
sodium chlorite can be activated in a buffer having a pH that is less than or equal to 5 or up to about 7.6
Data Source
AI summary
Disclosed are antiseptic compositions for disinfecting tissues, in particular for ocular use. Methods and compositions disclosed herein include sodium chlorite, optionally in combination with a surfactant.